Ashley Anne Tawfik, LPC-MHSP | |
6551 Stage Oaks Dr Ste 4, Bartlett, TN 38134-3895 | |
(901) 387-0026 | |
Not Available |
Full Name | Ashley Anne Tawfik |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 6551 Stage Oaks Dr Ste 4, Bartlett, Tennessee |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710507637 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 4087 (Tennessee) | Primary |
Entity Name | Clover Counseling Services, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265042253 PECOS PAC ID: 0749639912 Enrollment ID: O20231213001491 |
News Archive
Behavior problems, not depression, are linked to lower grades for depressed adolescents, according to a study in the December issue of the Journal of Health and Social Behavior.
FamilyCord, a subsidiary of California Cryobank, now provides direct cord blood and cord tissue services to Venezuelan families and has assumed management of clients of Cordon de Vida, one of Venezuela's largest cord blood banks.
Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the international market launch of the PyroTITAN™ Humeral Resurfacing Arthroplasty System at the American Academy of Orthopaedic Surgeons Annual Conference in New Orleans, LA, March 9-13, 2010. Designed to meet the unique soft tissue biocompatibility requirements of the shoulder joint, the PyroTITAN humeral resurfacing implant is the first commercially-available, human shoulder arthroplasty prosthesis made of PyroCarbon.
A collaboration of scientists including Professor Jean Patterson, Ph.D., of Texas Biomedical Research Institute, is working on a new way to detect Zika virus that will help guide clinicians in their treatment of patients with the disease.
A two-year trial of entecavir followed by lamivudine (LAM) in patients with chronic hepatitis B virus (HBV) infection resulted in a virologic rebound rate of 24% and 12% drug-resistance rate. Patients who continued on entecavir therapy throughout the study period had undetectable HBV DNA at the two-year endpoint. Details of this trial are published in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases..
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Ashley Anne Tawfik, LPC-MHSP 3449 Highland Park Pl, Memphis, TN 38111-4731 Ph: (901) 501-7526 | Ashley Anne Tawfik, LPC-MHSP 6551 Stage Oaks Dr Ste 4, Bartlett, TN 38134-3895 Ph: (901) 387-0026 |
News Archive
Behavior problems, not depression, are linked to lower grades for depressed adolescents, according to a study in the December issue of the Journal of Health and Social Behavior.
FamilyCord, a subsidiary of California Cryobank, now provides direct cord blood and cord tissue services to Venezuelan families and has assumed management of clients of Cordon de Vida, one of Venezuela's largest cord blood banks.
Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the international market launch of the PyroTITAN™ Humeral Resurfacing Arthroplasty System at the American Academy of Orthopaedic Surgeons Annual Conference in New Orleans, LA, March 9-13, 2010. Designed to meet the unique soft tissue biocompatibility requirements of the shoulder joint, the PyroTITAN humeral resurfacing implant is the first commercially-available, human shoulder arthroplasty prosthesis made of PyroCarbon.
A collaboration of scientists including Professor Jean Patterson, Ph.D., of Texas Biomedical Research Institute, is working on a new way to detect Zika virus that will help guide clinicians in their treatment of patients with the disease.
A two-year trial of entecavir followed by lamivudine (LAM) in patients with chronic hepatitis B virus (HBV) infection resulted in a virologic rebound rate of 24% and 12% drug-resistance rate. Patients who continued on entecavir therapy throughout the study period had undetectable HBV DNA at the two-year endpoint. Details of this trial are published in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases..
› Verified 5 days ago
Dr. Jamie Ray Pettit, ED.D LPC - MHSP Counselor Medicare: Medicare Enrolled Practice Location: 6630 Summer Knoll Cir, Bartlett, TN 38134 Phone: 901-746-9438 Fax: 901-746-9331 | |
Melanie A Gallimore, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 7410 Memphis Arlington Rd, Bartlett, TN 38135 Phone: 901-252-7859 | |
Christi Nash, LPC-MHSP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2810 Summer Oaks Dr Ste 9, Bartlett, TN 38134 Phone: 901-295-8225 | |
Katy Leech, LPC-MHSP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2855 Summer Oaks Dr, Bartlett, TN 38134 Phone: 901-250-2215 | |
Brittney Nicole Jackson, LPC-MHSP Counselor Medicare: Not Enrolled in Medicare Practice Location: 6551 Stage Oaks Dr Ste 4, Bartlett, TN 38134 Phone: 901-387-0026 Fax: 901-552-4737 | |
Talia Trigg, LPC-MHSP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8046 N Brother Blvd Ste 105, Bartlett, TN 38133 Phone: 901-779-3755 | |
Sylvia Thomas White, LPC-MHSP, RD, LDN Counselor Medicare: Medicare Enrolled Practice Location: 3025 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-384-0065 Fax: 901-266-1165 |